The impact of SGLT2 inhibitors on indices of cardiac function: An updated systematic review and meta-analysis

Back

HFA Premium Access

The impact of SGLT2 inhibitors on indices of cardiac function: An updated systematic review and meta-analysis

Session: Modern technologies in heart failure

Topic: Antidiabetic Pharmacotherapy

Speaker: Doctor P. Theofilis (Athens, GR)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Panagiotis Theofilis

Hippokration General Hospital, Athens (Greece)

0 follower

5 more presentations in this session

How to calculate the anaerobic threshold to stratify HF prognosis: a comparison between absolute value, percentage of peakVO2 or percentage of predicted maxVO2 ina large multicenter cohort of HFrEF

Speaker: Doctor E. Salvioni (Milan, IT)

An inflamed relationship - increase in serial galectin-3 identifies males at risk of developing heart failure and cancer.

Speaker: Mr F. Van Den Berg (Groningen, NL)

Protocol based versus mobile application based 6-minute walk test. A validation study

Speaker: Doctor L. Klompstra (Linkoping, SE)

The impact of renal denervation on diastolic function in patients with resistant hypertension and heart failure with preserved ejection fraction: one year follow-up

Speaker: Doctor A. Moiseeva (Chisinau, MD)

Machine learning models to predict elevated plasma NT-proBNP concentration in a clinical trial population

Speaker: Mr C. Li (Glasgow, GB)

Access the full session

Modern technologies in heart failure

Speakers: Doctor P. Theofilis, Doctor E. Salvioni, Mr F. Van Den Berg, Doctor L. Klompstra, Doctor A. Moiseeva...

Access

Video

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources